Recombinant HSV1 gG Envelope Protein (ab43048)
Key features and details
- Expression system: Escherichia coli
- Purity: > 95% SDS-PAGE
- Suitable for: ELISA, WB
製品の詳細
-
製品名
Recombinant HSV1 gG Envelope Protein -
生理活性
Immunoreactive with sera of HSV-infected individuals, excellent antigen for detection of HSV with minimal specificity problems. -
精製度
> 95 % SDS-PAGE.
Sepharose derived purification. -
発現系
Escherichia coli -
タンパク質長
Protein fragment -
Animal free
No -
由来
Recombinant -
-
配列の追加情報
The protein contains the HSV-1 gG immunodominant regions.
-
特性
Our Abpromise guarantee covers the use of ab43048 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
アプリケーション
ELISA
Western blot
-
製品の状態
Liquid -
Concentration information loading...
前処理および保存
-
保存方法および安定性
Shipped at 4°C. Store at -20°C.
Constituents: 0.395% Tris HCl, 0.0292% EDTA, 50% Glycerol
関連情報
-
別名
- GG
- Glycoprotein G
- Herpes simplex virus 1 glycoprotein G
see all -
関連性
Herpes simplex virus type 1 (HSV1) is usually associated with infections of the lips, mouth, and face. It is the most common herpes simplex virus and is usually acquired in childhood. HSV-1 often causes lesions inside the mouth such as cold sores (fever blisters) and is transmitted by contact with infected saliva. Glycoprotein G is suggested to contribute to viral entry through apical surfaces of polarized cells. -
細胞内局在
Viral envelope
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (1)
ab43048 は 1 報の論文で使用されています。
- Awasthi S et al. Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models. J Clin Invest 131:N/A (2021). PubMed: 34618692